Healthcare industry reported 97 deals worth $38.1 billion in Feb 2024
Deal value increased by 977 per cent in February 2024, compared to February 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Sustainable pharmaceuticals: Addressing environmental concerns
Dr Amit Pandit, School of Pharmacy & Technology Management, NMIMS, Indore & Shirpur Campuses, explores the imperative for…
GLP1 agonists set to become the best-selling drugs in 2024: GlobalData
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders
Sanofi India, Emcure Pharma announce exclusive distribution partnership
Emcure to distribute and promote Sanofi’s cardiovascular brands in India
Zydus launches IBYRA, the generic version of Olaparib
The drug will target specific genetic mutations prevalent in certain types of cancers
Biotech funding set for recovery in 2024: GlobalData
This optimism follows a downturn in private biotech venture financing, where funding in 2023 declined by 43.2 per cent and 52.3…
DOP amends PTUAS, expands eligibility criteria to include MSMEs
Offers flexible financing options, and focuses on reimbursement subsidies from 10-20 per cent to MSMEs
Emcure Pharma forays into OTC market with Galact supplement for breastfeeding mothers
Enriched with the potency of Shatavari and six other herbs, Galact is meticulously formulated to boost breast milk production for…
Venus Remedies gets UNICEF GMP approval
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry…
AstraZeneca India, Mankind Pharma sign pact to distribute asthma medicine in India
AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be…
Control Print acquires majority stake in UK-based Codeology Group for £1 million
Expands its business in the UK market, aiming to expand its product portfolio
Glenmark ranks No.1 in dermatologist prescriptions for protective emollients and derma therapy:…
Glenmark Pharmaceuticals has been ranked number 1 in dermatologists’ prescriptions in the protective emollients category and for…
Oncology dominates CRISPR landscape: GlobalData
Oncology accounts for 30 per cent of all active CRISPR drugs
Opportunities for cell and gene therapy landscape remain high but so does challenges: GlobalData
There are 694 CGTs in development across various therapy areas in the US as of February 2024
Strides gets USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg
Gabapentin tablets will be manufactured at the company’s facility in Puducherry
ICT Mumbai’s SATHI FOUNDATION (Mumbai Biocluster) gets 60 cr to accelerate biopharma innovation
The fund will be to accelerate the development of critical therapies for diseases like cancer, rare diseases, and infectious…
High ADHD comorbidity rates offer opportunity for pipeline products to capture market: GlobalData
Among the comorbidities associated with ADHD, key opinion leaders (KOLs) interviewed by GlobalData noted anxiety disorder,…
DKSH signs distribution pact with Lactalis in Asia and Europe
Lactalis provides high-purity pharma lactose to formulate oral solid dose medicines, conforming with the lactose monohydrate…
Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR:…
In addition to the FDA approval, EXBLIFEP has also been submitted for marketing approval in the EU and received a positive opinion…
Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara
Stelara (Ustekinumab) has been approved for the treatment of psoriasis, Crohn’s disease, ulcerative colitis, plaque psoriasis and…